CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Open-market sale Chief Patient Supply Officer sold 4,823 shares at $9.25 ($44,613)
- 4 Open-market sale Chief Business Officer sold 200,000 shares at $8.74 ($1,748,180)
- 4 Open-market sale Chief Executive Officer sold 2,788 shares at $9.25 ($25,789)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 33,000 shares at $1.62 ($53,460)
- 4 Open-market buy Director bought 12,900 shares at $1.89 ($24,381)
- 4 Open-market sale Director sold 500,000 shares at $9.33 ($4,666,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 7,500,000 shares at $0.67 ($5,000,250)
- 4 Open-market buy 10% owner bought 7,500,000 shares at $0.67 ($5,000,250)
- 4 Open-market buy Director bought 7,500,000 shares at $0.67 ($5,000,250)
Page 9 of 18 · 351 filings